Bionomics Past Earnings Performance

Past criteria checks 0/6

Bionomics's earnings have been declining at an average annual rate of -33.7%, while the Biotechs industry saw earnings growing at 10.6% annually. Revenues have been declining at an average rate of 33% per year.

Key information

-33.7%

Earnings growth rate

-11.9%

EPS growth rate

Biotechs Industry Growth-14.6%
Revenue growth rate-33.0%
Return on equity-88.6%
Net Marginn/a
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Bionomics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

DB:B1N0 Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 240-1589
31 Mar 240-18911
31 Dec 230-2170
30 Sep 230-2060
30 Jun 230-21913
31 Mar 232-1976
31 Dec 224-1750
30 Sep 224-1550
30 Jun 224-1550
31 Mar 222-1660
31 Dec 210-1660
30 Sep 211-1150
30 Jun 211-740
31 Mar 211-340
31 Dec 201140
30 Sep 202-240
30 Jun 202-430
31 Dec 194-340
30 Sep 195-540
30 Jun 195-760
31 Mar 196-1480
31 Dec 185-2080
30 Sep 187-1980
30 Jun 189-1980
31 Mar 1815-1270
31 Dec 1721-560
30 Sep 1721-560
30 Jun 1721-560
31 Mar 1717-980
31 Dec 1612-1290
30 Sep 1614-1390
30 Jun 1614-1280
31 Mar 1614-1480
31 Dec 1513-1570
30 Sep 1512-1360
30 Jun 1512-1370
31 Mar 1517-550
31 Dec 1424440
30 Sep 1425340
30 Jun 1425340
31 Mar 1418-450
31 Dec 1310-1150

Quality Earnings: B1N0 is currently unprofitable.

Growing Profit Margin: B1N0 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: B1N0 is unprofitable, and losses have increased over the past 5 years at a rate of 33.7% per year.

Accelerating Growth: Unable to compare B1N0's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: B1N0 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-20.4%).


Return on Equity

High ROE: B1N0 has a negative Return on Equity (-88.58%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies